vanilloid receptor 1 (VR1/TRPV1) -targeting RNAi (J&J PRD)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namevanilloid receptor 1 (VR1/TRPV1) -targeting RNAi (J&J PRD)
Drug Alias NameHSV/U6shTRPV1TRPV1 transgene plus U6 shRNA-expressing HSV vectorHSV/GFPmiRTrpv1TRPV1 transgene plus miRshRNA-expressing HSV vector
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy
Mechanisms of ActionVanilloid receptor antagonists
TargetsTransient receptor potential cation channel subfamily V member 1
Therapy Area/IndicationsPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJohnson & Johnson Pharmaceutical Research & Development LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJohnson & Johnson Pharmaceutical Research & Development LLC
Active IndicationsN/A
Inactive IndicationsPain

Other Information

ATC CodeN/A
Related LinksN/A